Phathom Pharmaceuticals (PHAT) Cost of Revenue (2023 - 2026)
Phathom Pharmaceuticals (PHAT) reported Cost of Revenue of $18.37 million for Q3 2026, up 196.7% from $6.19 million a year earlier and up 21.7% from the prior quarter.
Powered by 
Analysis
Phathom Pharmaceuticals (PHAT) Cost of Revenue (2023 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Phathom Pharmaceuticals' Cost of Revenue came in at $53.11 million, up 183.0% year-over-year; for FY2025, it was $22.6 million, up 183.4% from FY2024.
- By year, Cost of Revenue came in at $7.97 million in FY2024 and $167,000 in FY2023.
- The Q3 2026 figure ranks as the highest quarterly Cost of Revenue in data going back to Q4 2023.
- Year over year, Cost of Revenue has now increased in each of the last seven quarters, with growth averaging 274.6% over the last seven quarters.
- Per Business Quant data, the three quarters before Q3 2026 came in at $15.1 million (Q2 2026), $12 million (Q1 2026) and $7.65 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.93 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.29 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 2.95 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.79 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.57 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.03 Bn |
| 10 | Phathom Pharmaceuticals | 442.66 Mn | -246.70 Mn | 66.36 Mn | 18.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 18.37 Mn |
| Jun 30, 2026 | 15.10 Mn |
| Mar 31, 2026 | 12.00 Mn |
| Dec 31, 2025 | 7.65 Mn |
| Sep 30, 2025 | 6.19 Mn |
| Jun 30, 2025 | 5.04 Mn |
| Mar 31, 2025 | 3.72 Mn |
| Dec 31, 2024 | 3.82 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 426,000.00 |
| Dec 31, 2023 | 167,000.00 |
API Access
Phathom Pharmaceuticals Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=PHAT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "PHAT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=PHAT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();